Journal ArticleOPEN ACCESS

Myocarditis Surveillance in Patients with Advanced Melanoma on Combination Immune Checkpoint Inhibitor Therapy: The Memorial Sloan Kettering Cancer Center Experience

  • Lee Chuy K
  • Oikonomou E
  • Postow M
  • et al.
The Oncologist (2019) 24(5) e196-e197
DOI: 10.1634/theoncologist.2019-0040
36Citations
Citations of this article
43Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This letter to the editor describes myocarditis screening among patients undergoing combination immune checkpoint inhibitor therapy, in light of the consensus document from the Checkpoint Inhibitor Safety Working Group.

Cite

CITATION STYLE

APA

Lee Chuy, K., Oikonomou, E. K., Postow, M. A., Callahan, M. K., Chapman, P. B., Shoushtari, A. N., … Gupta, D. (2019). Myocarditis Surveillance in Patients with Advanced Melanoma on Combination Immune Checkpoint Inhibitor Therapy: The Memorial Sloan Kettering Cancer Center Experience. The Oncologist, 24(5), e196–e197. https://doi.org/10.1634/theoncologist.2019-0040

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free